NCT00455624View on ClinicalTrials.gov

Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

Androgen deprivation therapy

According to standard medical care

Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

02215

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00455624 - Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer | Biotech Hunter | Biotech Hunter